MOBERG DERMA SIGNS COMMERCIAL AGREEMENT FOR NAIL FUNGUS PRODUCT K101 WITH LEADING NORDIC OTC COMPANY
Moberg Derma AB today announces a license and co-promotion agreement with a leading Nordic OTC company for K101 - Moberg Derma's novel treatment for nail fungus (onychomycosis). In the agreement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results